Explore how decentralization and innovative approaches are transforming rare disease drug development.
This whitepaper by Ergomed CRO examines the benefits of decentralized clinical trials, digital health technologies, real-world data, and precision medicine in accelerating patient access, improving data collection, and reducing costs in rare disease research.